GEN Exclusives

More »
New Products

Related to IS THERE MORE FUNCTIONAL DNA IN THE GENOME THAN WE THOUGHT

    • Stabilized Pepsin
    • SciGene
    • CytoZyme™ stabilized pepsin is an advanced formulation for pretreating tissue samples in nucleic acid probe-based cytogenetic assays including FISH. CytoZyme is a ready-to-use solution of purified pepsin that can be stored in the refrigerator witho
    • Sequencing System
    • Pacific Biosciences
    • The PacBio RS II allows scientists to generate finished genome assemblies, reveal and understand epigenomes, and characterize genomic variation. Based on the SMRT sequencing technology, the RS II can generate average read lengths of 5,000 base pair
    • DNA Enrichment Kit
    • New England BioLabs
    • The NEBNext® Microbiome DNA enrichment kit can separate microbial DNA from host DNA. The kit utilizes the MBD2-Fc protein, which can bind to CpG-methylated DNA (including human genomic DNA) with high specificity. The MDB2-Fc protein is attache
    • DNA Extraction Kit
    • Igen Biotech
    • iGEN Hemokit™ is a genomic DNA extraction technology based on classic organic-phase extraction, avoiding the use of silica columns. Because this approach reduces fragmentation, it provides DNA that can be applied in sensitive downstream analyses su
    • Kits for Analyzing Modified Cytosines
    • Cambridge Epigenetix
    • TrueMethyl™ kits provide quantitative, accurate and repeatable single-base resolution sequencing of the modified bases hydroxymethylcytosine (5-hmC) and methylcytosine (5-mC) in genomic DNA. This capability is attributable to the kits’ utiliza
  • Page 1 of 1 (5 items) 1 

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?